Diebold Nixdorf, Incorporated ( DBD) - Stock Earnings
DBD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
DBD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 49.6 million USD | 1.1 billion USD |
| 2026Q1 | 5.0 million USD | 891.8 million USD |
| 2026Q2 | 15.5 million USD | 930.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DBD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.4 billion USD | 3.8 billion USD |
| 2024 | -16.5 million USD | 3.8 billion USD |
| 2025 | 94.6 million USD | 3.8 billion USD |
| 2026 Est. | — | — |
DBD
Price: $65.04
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.02 USD
P/E Ratio: 21.12
Exchange: NYQ
Sector: Technology
Industry: Software - Application
Volume: 1.9 million
Ebitda: 81.7 millionMarket Capitalization: 2.2 billion